Red blood cell folate and plasma folate are not associated with risk of incident colorectal cancer in the Women's Health Initiative observational study

Marian L. Neuhouser, Ting Yuan David Cheng, Shirley A A Beresford, Elissa Brown, Xiaoling Song, Joshua W. Miller, Yingye Zheng, Cynthia A. Thomson, James M. Shikany, Mara Z. Vitolins, Thomas E. Rohan, Ralph Green, Cornelia M. Ulrich

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The relationship between folate and colorectal cancer (CRC) risk is unclear. We investigated the association of two biomarkers of folate status, plasma folate and red blood cell (RBC) folate, with CRC risk using a nested case-control design in the Women's Health Initiative Observational Study. Postmenopausal women (n = 93,676) aged 50-79 years were enrolled in the Women's Health Initiative Observational Study (1993-1998). A fasting blood draw and extensive health, dietary and lifestyle data were collected upon enrollment. Through 2008, 988 incident CRC cases were reported and confirmed with medical records adjudication. Cases and controls were matched on age (±3 years), enrollment date (±1 year), race/ethnicity, blood draw date (±6 months) and hysterectomy status. Plasma and RBC folate were determined by radio assay. Folate biomarker values were divided into quartiles, and conditional logistic regression estimated odds ratios (ORs) and 95% confidence intervals (CI) for the associations of folate with total CRC, by tumor site and by stage at diagnosis. Additional analyses examined whether risks varied across time periods corresponding to the United States folic acid fortification policy: prefortification (1994-1995), perifortification (1996-1997) and postfortification (1998). ORs for overall CRC risk comparing Q4 vs. Q1 were 0.91 (95% CI 0.67-1.24) and 0.91 (95% CI 0.67-1.23) for RBC and plasma folate, respectively. There were no changes in risk attributable to food supply fortification. These results do not support an overall association of folate with CRC risk and suggest that folic acid fortification of the US food supply did not alter the associations in these postmenopausal women. What's new? Poor intake of the B-vitamin folate has been associated with increased risk of colorectal cancer (CRC). However, some studies suggest that very high intakes of folate may increase CRC risk. Given that certain foods are now fortified with folic acid in the U.S., it's important to ascertain whether fortification might increase CRC risk in the general population. In this large study of folate status, the authors found no evidence that folate fortification increases the risk of CRC.

Original languageEnglish (US)
Pages (from-to)930-939
Number of pages10
JournalInternational Journal of Cancer
Volume137
Issue number4
DOIs
StatePublished - Aug 15 2015

Fingerprint

Women's Health
Folic Acid
Observational Studies
Colorectal Neoplasms
Erythrocytes
Food Supply
Confidence Intervals
Biomarkers
Odds Ratio
Fortified Food
Vitamin B Complex
Hysterectomy
Radio
Medical Records
Life Style

Keywords

  • colorectal cancer
  • folate
  • observational studies
  • postmenopausal women

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Red blood cell folate and plasma folate are not associated with risk of incident colorectal cancer in the Women's Health Initiative observational study. / Neuhouser, Marian L.; Cheng, Ting Yuan David; Beresford, Shirley A A; Brown, Elissa; Song, Xiaoling; Miller, Joshua W.; Zheng, Yingye; Thomson, Cynthia A.; Shikany, James M.; Vitolins, Mara Z.; Rohan, Thomas E.; Green, Ralph; Ulrich, Cornelia M.

In: International Journal of Cancer, Vol. 137, No. 4, 15.08.2015, p. 930-939.

Research output: Contribution to journalArticle

Neuhouser, ML, Cheng, TYD, Beresford, SAA, Brown, E, Song, X, Miller, JW, Zheng, Y, Thomson, CA, Shikany, JM, Vitolins, MZ, Rohan, TE, Green, R & Ulrich, CM 2015, 'Red blood cell folate and plasma folate are not associated with risk of incident colorectal cancer in the Women's Health Initiative observational study', International Journal of Cancer, vol. 137, no. 4, pp. 930-939. https://doi.org/10.1002/ijc.29453
Neuhouser, Marian L. ; Cheng, Ting Yuan David ; Beresford, Shirley A A ; Brown, Elissa ; Song, Xiaoling ; Miller, Joshua W. ; Zheng, Yingye ; Thomson, Cynthia A. ; Shikany, James M. ; Vitolins, Mara Z. ; Rohan, Thomas E. ; Green, Ralph ; Ulrich, Cornelia M. / Red blood cell folate and plasma folate are not associated with risk of incident colorectal cancer in the Women's Health Initiative observational study. In: International Journal of Cancer. 2015 ; Vol. 137, No. 4. pp. 930-939.
@article{cd05f1f11c3141d1af5bc2b9a216de12,
title = "Red blood cell folate and plasma folate are not associated with risk of incident colorectal cancer in the Women's Health Initiative observational study",
abstract = "The relationship between folate and colorectal cancer (CRC) risk is unclear. We investigated the association of two biomarkers of folate status, plasma folate and red blood cell (RBC) folate, with CRC risk using a nested case-control design in the Women's Health Initiative Observational Study. Postmenopausal women (n = 93,676) aged 50-79 years were enrolled in the Women's Health Initiative Observational Study (1993-1998). A fasting blood draw and extensive health, dietary and lifestyle data were collected upon enrollment. Through 2008, 988 incident CRC cases were reported and confirmed with medical records adjudication. Cases and controls were matched on age (±3 years), enrollment date (±1 year), race/ethnicity, blood draw date (±6 months) and hysterectomy status. Plasma and RBC folate were determined by radio assay. Folate biomarker values were divided into quartiles, and conditional logistic regression estimated odds ratios (ORs) and 95{\%} confidence intervals (CI) for the associations of folate with total CRC, by tumor site and by stage at diagnosis. Additional analyses examined whether risks varied across time periods corresponding to the United States folic acid fortification policy: prefortification (1994-1995), perifortification (1996-1997) and postfortification (1998). ORs for overall CRC risk comparing Q4 vs. Q1 were 0.91 (95{\%} CI 0.67-1.24) and 0.91 (95{\%} CI 0.67-1.23) for RBC and plasma folate, respectively. There were no changes in risk attributable to food supply fortification. These results do not support an overall association of folate with CRC risk and suggest that folic acid fortification of the US food supply did not alter the associations in these postmenopausal women. What's new? Poor intake of the B-vitamin folate has been associated with increased risk of colorectal cancer (CRC). However, some studies suggest that very high intakes of folate may increase CRC risk. Given that certain foods are now fortified with folic acid in the U.S., it's important to ascertain whether fortification might increase CRC risk in the general population. In this large study of folate status, the authors found no evidence that folate fortification increases the risk of CRC.",
keywords = "colorectal cancer, folate, observational studies, postmenopausal women",
author = "Neuhouser, {Marian L.} and Cheng, {Ting Yuan David} and Beresford, {Shirley A A} and Elissa Brown and Xiaoling Song and Miller, {Joshua W.} and Yingye Zheng and Thomson, {Cynthia A.} and Shikany, {James M.} and Vitolins, {Mara Z.} and Rohan, {Thomas E.} and Ralph Green and Ulrich, {Cornelia M.}",
year = "2015",
month = "8",
day = "15",
doi = "10.1002/ijc.29453",
language = "English (US)",
volume = "137",
pages = "930--939",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Red blood cell folate and plasma folate are not associated with risk of incident colorectal cancer in the Women's Health Initiative observational study

AU - Neuhouser, Marian L.

AU - Cheng, Ting Yuan David

AU - Beresford, Shirley A A

AU - Brown, Elissa

AU - Song, Xiaoling

AU - Miller, Joshua W.

AU - Zheng, Yingye

AU - Thomson, Cynthia A.

AU - Shikany, James M.

AU - Vitolins, Mara Z.

AU - Rohan, Thomas E.

AU - Green, Ralph

AU - Ulrich, Cornelia M.

PY - 2015/8/15

Y1 - 2015/8/15

N2 - The relationship between folate and colorectal cancer (CRC) risk is unclear. We investigated the association of two biomarkers of folate status, plasma folate and red blood cell (RBC) folate, with CRC risk using a nested case-control design in the Women's Health Initiative Observational Study. Postmenopausal women (n = 93,676) aged 50-79 years were enrolled in the Women's Health Initiative Observational Study (1993-1998). A fasting blood draw and extensive health, dietary and lifestyle data were collected upon enrollment. Through 2008, 988 incident CRC cases were reported and confirmed with medical records adjudication. Cases and controls were matched on age (±3 years), enrollment date (±1 year), race/ethnicity, blood draw date (±6 months) and hysterectomy status. Plasma and RBC folate were determined by radio assay. Folate biomarker values were divided into quartiles, and conditional logistic regression estimated odds ratios (ORs) and 95% confidence intervals (CI) for the associations of folate with total CRC, by tumor site and by stage at diagnosis. Additional analyses examined whether risks varied across time periods corresponding to the United States folic acid fortification policy: prefortification (1994-1995), perifortification (1996-1997) and postfortification (1998). ORs for overall CRC risk comparing Q4 vs. Q1 were 0.91 (95% CI 0.67-1.24) and 0.91 (95% CI 0.67-1.23) for RBC and plasma folate, respectively. There were no changes in risk attributable to food supply fortification. These results do not support an overall association of folate with CRC risk and suggest that folic acid fortification of the US food supply did not alter the associations in these postmenopausal women. What's new? Poor intake of the B-vitamin folate has been associated with increased risk of colorectal cancer (CRC). However, some studies suggest that very high intakes of folate may increase CRC risk. Given that certain foods are now fortified with folic acid in the U.S., it's important to ascertain whether fortification might increase CRC risk in the general population. In this large study of folate status, the authors found no evidence that folate fortification increases the risk of CRC.

AB - The relationship between folate and colorectal cancer (CRC) risk is unclear. We investigated the association of two biomarkers of folate status, plasma folate and red blood cell (RBC) folate, with CRC risk using a nested case-control design in the Women's Health Initiative Observational Study. Postmenopausal women (n = 93,676) aged 50-79 years were enrolled in the Women's Health Initiative Observational Study (1993-1998). A fasting blood draw and extensive health, dietary and lifestyle data were collected upon enrollment. Through 2008, 988 incident CRC cases were reported and confirmed with medical records adjudication. Cases and controls were matched on age (±3 years), enrollment date (±1 year), race/ethnicity, blood draw date (±6 months) and hysterectomy status. Plasma and RBC folate were determined by radio assay. Folate biomarker values were divided into quartiles, and conditional logistic regression estimated odds ratios (ORs) and 95% confidence intervals (CI) for the associations of folate with total CRC, by tumor site and by stage at diagnosis. Additional analyses examined whether risks varied across time periods corresponding to the United States folic acid fortification policy: prefortification (1994-1995), perifortification (1996-1997) and postfortification (1998). ORs for overall CRC risk comparing Q4 vs. Q1 were 0.91 (95% CI 0.67-1.24) and 0.91 (95% CI 0.67-1.23) for RBC and plasma folate, respectively. There were no changes in risk attributable to food supply fortification. These results do not support an overall association of folate with CRC risk and suggest that folic acid fortification of the US food supply did not alter the associations in these postmenopausal women. What's new? Poor intake of the B-vitamin folate has been associated with increased risk of colorectal cancer (CRC). However, some studies suggest that very high intakes of folate may increase CRC risk. Given that certain foods are now fortified with folic acid in the U.S., it's important to ascertain whether fortification might increase CRC risk in the general population. In this large study of folate status, the authors found no evidence that folate fortification increases the risk of CRC.

KW - colorectal cancer

KW - folate

KW - observational studies

KW - postmenopausal women

UR - http://www.scopus.com/inward/record.url?scp=84931564612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931564612&partnerID=8YFLogxK

U2 - 10.1002/ijc.29453

DO - 10.1002/ijc.29453

M3 - Article

C2 - 25643945

AN - SCOPUS:84931564612

VL - 137

SP - 930

EP - 939

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 4

ER -